<PAGE>
September 10, 1999
VIA EDGAR
Heather Maples, Esq.
Securities and Exchange Commission
Division of Corporate Finance
450 Fifth Street, N.W.
Washington, DC 20549
Re: Clontech Laboratories, Inc.
CIK: 0000816281
Commission File No. 333-72607 Application for Withdrawal
Ladies and Gentlemen:
Pursuant to Rule 477(a) promulgated under the Securities Act of 1933, as
amended, the undersigned registrant (the "Registrant") hereby applies for an
order granting the immediate withdrawal of its Registration Statement on Form
S-1, together with all exhibits and amendments thereto, Commission File No.
333-72607 (collectively, the "Registration Statement"). The Registration
Statement was originally filed with the Securities and Exchange Commission (the
"Commission") on February 19, 1999.
Pursuant to the Registration Statement, the Registrant proposed to register
certain shares of its Common Stock, $0.001 par value per share (the "Shares"),
for issuance to the public with a proposed maximum offering price of
$73,600,000. The Registrant has recently consummated a transaction with Becton,
Dickinson and Company ("Becton") whereby the Registrant has become a wholly
owned subsidiary of Becton. No securities have been sold under the Registration
Statement and all activity in pursuit of the offering has been discontinued.
Accordingly, we request an order granting the withdrawal of the Registration
Statement be issued by the Commission as soon as possible.
<PAGE>
If you have any questions regarding the foregoing application for withdrawal,
please contact Matthew H. Hemington of Cooley Godward LLP, legal counsel to the
Registrant in connection with the Registration Statement, at (650) 843-5062.
Sincerely,
Clontech Laboratories, Inc.
/s/ Kenneth S. Fong
Kenneth S. Fong
President and Chief Executive Officer
Cc: Matthew Hemington, Esq.
Jason A. Mendelson, Esq.
Gary DeFazio, Esq.
